Haemodialysis Clinical Trials

15 recruiting

Haemodialysis Trials at a Glance

13 actively recruiting trials for haemodialysis are listed on ClinicalTrialsFinder across 6 cities in 7 countries. The largest study group is Phase 2 with 4 trials, with the heaviest enrollment activity in Wuhu, Berlin, and Bologna. Lead sponsors running haemodialysis studies include First Affiliated Hospital of Wannan Medical College, Chris McIntyre, and Charite University, Berlin, Germany.

Browse haemodialysis trials by phase

Treatments under study

About Haemodialysis Clinical Trials

Looking for clinical trials for Haemodialysis? There are currently 15 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Haemodialysis trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Haemodialysis clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 113 of 13 trials

Recruiting

Internal Jugular Vein Ultrasound for Volume Status Assessment in Haemodialysis

Point of Care Ultrasound (POCUS)HaemodialysisVolume Assessment
University of Bologna100 enrolled1 locationNCT07438613
Recruiting
Phase 1Phase 2

To Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of KN060 in ESRD Dialysis Patients

End-Stage Renal Disease Requiring Haemodialysis
Suzhou Alphamab Co., Ltd.12 enrolled1 locationNCT07201467
Recruiting

Predictive Value of Carotid Ultrasonography for Intradialytic Hypotension

HemodialysisIntradialytic HypotensionUremia; Chronic+1 more
First Affiliated Hospital of Wannan Medical College183 enrolled1 locationNCT07033260
Recruiting

Inferior Vena Cava Collapsibility Index and Intradialytic Hypotension

Intradialytic HypotensionEnd-Stage Renal Disease Requiring Haemodialysis
First Affiliated Hospital of Wannan Medical College188 enrolled1 locationNCT07033273
Recruiting

Pleth Variability Index for Predicting Low Blood Pressure During Maintenance Hemodialysis

HemodialysisHypotension and ShockIntradialytic Hypotension+1 more
First Affiliated Hospital of Wannan Medical College200 enrolled1 locationNCT07022847
Recruiting

Behind the Needle: Healthcare Professionals' Perspectives on HD Needling

DialysisPerspective of Healthcare Professionals Haemodialysis Needling
East and North Hertfordshire NHS Trust16 enrolled1 locationNCT06845605
Recruiting

Sodium Deposition in Soft Tissues of Patients with Kidney Disease

Haemodialysis Complication
Chris McIntyre400 enrolled1 locationNCT03004547
Recruiting
Phase 2

Lumasiran in Hyperoxalaemic Patients on Haemodialysis

Cardiovascular DiseaseCardiovascular Risk FactorChronic Kidney Disease Requiring Chronic Dialysis+2 more
Charite University, Berlin, Germany50 enrolled1 locationNCT06225544
Recruiting

Comparison of EMLA cream with piroxicam gel for reducing pain associated with needling of arteriovenous fistula during haemodialysis

Haemodialysis
Samia Shaheen16 enrolled1 locationACTRN12622000943741
Recruiting
Phase 4

INFERR - Iron Infusion in Haemodialysis Study: Effect of Intravenous Iron Polymaltose on survival and hospitalisation rates for Indigenous Patients with High Ferritin Levels on Haemodialysis

high ferritinlow transferrin saturationHaemodialysis
Menzies School of Health Research576 enrolled2 locationsACTRN12620000705987
Recruiting

Multidisciplinary assessment at dialysis entry (MADE) study

Peritoneal DialysisHaemodialysis
Royal Adelaide Hospital160 enrolled3 locationsACTRN12618000190202
Recruiting
Phase 2

Inflammation and Colchicine use in patients with ESRF undergoing Dialysis

Chronic Kidney DiseaseInflammationHaemodialysis
A/Prof Sanjay Patel100 enrolled1 locationACTRN12617000922370
Recruiting
Phase 2

Investigation of whether metformin can be used safely and effectively in patients with type 2 diabetes on haemodialysis

Chronic Renal failure on haemodialysisType 2 Diabetes
Dr Tilenka Thynne6 enrolled1 locationACTRN12612000352808